Join the Tarceva group to help and get support from people like you.
Tarceva News
FDA Approves Tarceva as a Maintenance Therapy for Advanced Non-Small Cell Lung Cancer
MELVILLE, N.Y., Apr 16, 2010 (BUSINESS WIRE) – OSI Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the daily pill Tarceva (erlotinib) as a maintenance...
FDA Medwatch Alert: Tarceva (erlotinib) - May 8, 2009
OSI, Genentech and FDA notified healthcare professionals of new safety information added to the WARNINGS AND PRECAUTIONS sections of the prescribing information for Tarceva. Gastrointestinal...
FDA Medwatch Alert: Tarceva (erlotinib) - September 23, 2008
[Posted 09/23/2008] OSI and Genentech notified healthcare professionals that cases of hepatic failure and hepatorenal syndrome, including fatalities, have been reported during use of Tarceva,...
Ask a question
To post your own question to this support group, sign in or create an account.